Evidence map›Paper›PMID 39997937›Full record

ArticleToxics2025

The Acute Toxicity and Cardiotoxic Effects of Levofloxacin on Zebrafish (

Yixiao Wu, Wenjing Yu, Zhenyan Song, Jiawei He, Ze Li, Qi Chen, Shiwei Wang, Ping Li, Shaowu Cheng

Abstract read
In one paragraph

Article in Toxics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Frontiers in nutrition · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yixiao WuSchool of Integrated Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha 410208, China.
Wenjing YuSchool of Integrated Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha 410208, China.
Zhenyan SongSchool of Integrated Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha 410208, China.
Jiawei HeSchool of Integrated Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha 410208, China.
Ze LiSchool of Integrated Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha 410208, China.
Qi ChenSchool of Integrated Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha 410208, China.
Shiwei WangSchool of Integrated Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha 410208, China.
Ping LiSchool of Integrated Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha 410208, China.
Shaowu ChengSchool of Integrated Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha 410208, China.ORCID 0000-0001-6148-9565

Funding

Postgraduate Scientific Research Innovation Project of Hunan Province 2024CX013Postgraduate Scientific Research Innovation Project of Hunan Province 2024CX048Provincial Discipline Construction Project of Hunan University of Chinese Medicine (Integrated Traditional Chinese and Western Medicine) 22JBZ015the Hunan provincial "Shennong Talent" projectthe National Natural Science Foundation of China 82074046the Natural Science Foundation of Hunan Province for Excellent Youth Project 2023JJ20033the Science and Technology Innovation Program of Hunan Province 2023RC3166the Science and Technology Innovation Program of Hunan Province 2024RC1060the Scientific Research Fund of Hunan Provincial Education Department 23A0297the Scientific Research Fund of Hunan Provincial Education Department 23B0373
6 · The paper itself

Abstract

Emerging contaminants refer to chemical substances that have not been widely regulated but possess the potential to cause adverse effects on both the environment and human health. Antibiotics, as emerging contaminants, pose significant threats to ecosystems and human health due to their widespread use and persistence in the environment. Levofloxacin, a broad-spectrum fluoroquinolone antibiotic, is commonly employed in the treatment of bacterial infections, and has been frequently detected in environmental matrices and freshwater systems. In this study, we assessed the effects of levofloxacin on hatchability, mortality rates, malformations, behavioral changes, and cardiac development in zebrafish embryos by exposing them to varying concentrations of levofloxacin (0, 0.5, 1, 2, 4, and 8 mM). Our results demonstrate that levofloxacin exposure significantly impaired the growth and development of zebrafish larvae, particularly at higher concentrations. Notable effects included reduced body length, abnormal yolk sac and swim bladder development, pericardial edema, prolonged distances between the sinus venosus and arteriolar bulb (SV-BA), and disruptions in heart rate. Quantitative PCR analysis further revealed that levofloxacin exposure significantly upregulated the expression of key cardiac development genes in zebrafish larvae, including

Indexed as

cardiotoxicityembryotoxicityemerging contaminantsgene expressionlevofloxacinzebrafish

Identifiers

PMID39997937
PMCPMC11861866

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.